Cogent Biosciences Reports Recent Business Highlights and Second Quarter 2025 Financial Results
Provided By GlobeNewswire
Last update: Aug 5, 2025
Reported positive top-line results from SUMMIT evaluating bezuclastinib in patients with NonAdvanced Systemic Mastocytosis, achieving statistical significance across all primary and key secondary endpoints
Read more at globenewswire.com
